In the BM of MDS patients, IL-8, IP10, MCP-1, and IL-27 are significantly higher in both low- and high-risk MDS compared with healthy subjects, and levels increased during hypomethylating agent treatment [84]. Here, CXCL8 is linked to myelodysplastic syndrome.